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Summary 
Petroleum ether and methylene chloride extracts of Peperomia galioides and three prenylated 
diphenols, grifolic acid, grifolin and piperogalin exhibited in vitro antileishmanial activity. Dur- 
ing the course of infection of BALBlc mice with Leishmania amazomiisis, the treatments with 
each of these compounds did not influence the progression of the disease. 
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Introduction 
Leishmaniasis is a parasitic disease that affects 12 million 
people in the world and 350 million at risk, of whom some 
1.5 to 2 million will be infected each year (World Health 
Organization, 1995). Pentavalent antimonials in the form 
of sodium stibogluconate (Pentosta") or meglumine anti- 
monate (Glucantime@) are the drugs of choice for treatment 
of all forms of leishmaniasis but require long- term therapy 
and often induce toxic effects. 
In Bolivia, we have developed a searching program for 
Bolivian plants containing new natural active compounds 
against leishmaniasis (Fournet et al., 1994) In the in vitro 
preliminar screening, the petroleum ether and chloroformic 
extracts of whole plant, Peperomia galioides H. B. IC. (Pi- 
peraceae) displayed activity at 25 pg/ml against three 
strains of Leishmania ssp., L. amazonemis, L. braziliensis 
and L. donovaai. P. galioides is an herbaceous plant which 
grows at an altitude of 3500-2500 m in the Andean moun- 
tains. To our knowledge, this plant is not used in tradition- 
al medicine. In a previous study, we have isolated and iden- 
tified by fractionation and purification monitored by bioas- 
says, three prenylated-diphenols compounds, grifolic acid, 
grifolin and piperogalin (Mahiou et al., 1995). The present 
paper describes the in vitro and in vivo antileishmanicidal 
effects of these compounds as well as the activity of the in- 
itial crude extracts of P. galioides. 
Materials and Methods 
Chemicals 
The prenylated-diphenols, grifolin, piperogalin and gri- 
folic acid were isolated from Peperomia galioides H. B. K. 
The plant was collected in Unduavi (Bolivia) in April 1986 
by A. Fournet and identified by D. H. Valdebenito (Ohio 
State University, Columbus, Ohio, USA). Voucher speci- 
mens are deposited (AF 615) in the National Herbarium of 
Bolivia (La Paz). The isolation was performed by fractiona- 
tion and purification monitored by bioassays as previously 
described (Mahiou et al., 1995). Physical and spectral data 
(proton and 13carbon nuclear magnetic resonance and mass 
spectrometry) were used to control the purity of terpenoids. 
The structures of terpenoids are shown in Fig. 1. N-Methyl- 
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glucamine antimonate (Glucantimeo) equivalent to 
0.28 mg Sb'/ml was purchased from Rhône-Poulenc, Paris, 
France. 
Bio logica1 assays 
Cultitre and maintenance of the proinastigote forms of 
Leishmania ssp. The maintenance, cultivation, and isola- 
tion of promastigote-stage parasites have been described in 
detail elsewhere (Fournet et. al., 1994). The ICsos, which 
represent the drug concentration required to inhibit para- 
site growth by 90%, were evaluated from the plot of log 
dose versus parasite growth expressed as a percentage of 
the value for the control ans are the means of at  least two 
independent experiments performed in triplicate with dif- 
ferent stock drug solutions. 
Experimental animals. Female and male BALB/c mice 
were supplied by the IFFA-CREDO, France, and bred at the 
Instituto de Investigaciones en Ciencias de la Salud (IICS), 
Asuncion, Paraguay. Golden hamsters (Mesocritus aztratus) 
were used to maintain the parasites. 
Infection 
L. amazonensis MHOM/IFLA/BR/67/PH8 was used and 
maintained by passage every 6 to 8 weeks in hamsters. 
BALB/c (n  = 8) were inoculated in the right hind footpad 
with 2x106 amastigotes obtained from donor hamsters. 
The parasites were delivered in 100 p1 of phosphate buf- 
fered saline (PBS). Lesion development was monitored by 
serial measurements of footpad thickness with a dial gauge 
caliper (OSI, France). Size was expressed as the difference 
in thickness between the infected footpad and contralateral 
uninfected footpad. Measurements commenced one day 
prior to the inoculation of amastigotes and were continued 
between 8 to 12 weeks. 
Drug treatment 
The treatments were initiated four weeks after inocula- 
tion when infection was well established and lesions were 
obvious. Two days before administration of treatments 
the mice were randomly divided into groups of six. N- 
Methylglucamine antimonate was dissolved in 50 p1 of 
PBS and administered to BALB/c mice in regimen of 
100 mg per kg of body weight daily for 15 days by subcu- 
taneous route. The terpenoids and petroleum ether or 
CH2C12 extracts of P. galioides were tested at dose level of 
25 mg/kg and were dissolved in 40 p1 PBS, 5 pl of poly- 
sorbate (Tween 80, OSI, France) and 5 pl of dimethylsul- 
foxide (DMSO). Drugs were administered orally once dai- 
ly for 15 days or by subcutaneous route for 10 days. The 
untreated group received daily 40 p1 of PBS, 5 pl of 
Tween 80 and 5 pl of DMSO. 
Effect of treatment 
The animals were sacrified ten days after cessation of 
treatment to assess parasitological loads in the infected 
footpad. Briefly, the mice were killed and the lesions of in- 
fected footpad were excised, weighed and homogenized 
with a tissue glass grinder Potter in 5 ml of RPMI 1640 me- 
dium (Gibco, France) supplemented with 10% fetal calf 
serum, 1 ml of glutamine (GIBCO, France) at 29,4 mg/l, 
penicillin (100 U/ml) and streptomycin (100 pg/ml). Plates 
were examined and the number of amastigotes per host le- 
sion cell nucleus were counted. The number of amastigotes 
per lesion per nucleus x lesion weight in gram (lo') is ap- 
proximately equal to the total number of amastigotes per 
organ (Buffet et al., 1995; Stauber et. al., 1958). Parasite 
suppression was calculated from the ratio of the mean le- 
sion amastigote counts of drug-treated mice and the mean 
lesion amastigote counts of untreated mice multiplied by 
100 to obtain the percentage of parasite suppression. 
Statistical analysis. Data given means f standard devia- 
tions, unless indicated otherwise. Comparison of parasite 
suppression in the infected footpad of the untreated control 
group and drug-treated group was analyzed by two-way 
analysis of variance (ANOVA) and by Student's t test. Data 
were considered statistically significant at P<0.05. Analyses 
were performed on a personal computer with Excel 5.0a. 
Results and discussion 
In vitro studies 
The antileishmanial activity of P. galioides and three pre- 
nylated diphenols, grifolin, piperogalin and grifolic acid is 
presented in Table 1, and also for comparison, results ob- 
tained with two leishmanicidal reference drugs, meglumine 
antimonate and pentamidine. The crude extracts of P. gali- 
oides showed activity against three strains of Leishmania at 
100 pg/ml. The fractionation and purification, monitored 
by bioassays, led to isolation of three compounds, identi- 
Table 1. In vitro antileishmanial activity (IC90 (mg/ml) of total 
extracts of P. galioides and prenylated diphenols. 
IC,, (!-u@) 
Compounds L.b.Z L.d.4 
(2903) (PH 8) (H-142) (HS 70) 
Petroleum ether extract 100 100 100 100 
Methylene chloride extract 100 100 100 100 
Piperogalin 15 15 15 15 
Grifolin 20 20 20 20 
Grifolic acid 100 100 100 100 
Pentamidinel 1 1 1 1 
N-methylglucamine 
antimonatel >loo >loo  >loo >loo 
Reference drugs 
Leishmania braziliensis, 3Leishmania amazonensis, 4Leishmania 
donovani 
i 
~~ ~~ __ 
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OH 15' 14' 13' fied as piperogalin, grifolin and grifolic acid. The IC, val- 
ues of piperogalin, grifolin and grifolic acid were 15 pg/ml, 
20 pg/ml and 100 pglml respectively. These compounds 
were described by Mahiou et al., 1995. The chemical struc- 
tures of the products are presented in Fig. 1. 
12' 
1 R= COOH, Grifolic acid 
2 R=H, Grifolin 
H3C 7 v  OH 
R In vivo studies 
The results obtained with Glucantime@, P. galioides ex- 
tracts, grifolin, grifolic acid and piperogalin treatments on 
the development of L. amazonensis lesions in BALBIc are 
presented in Tab. 2. The subcutaneous treatment with anti- 
monial agent at 100 mg/kg for fifteen days reduced signifi- 
cally the lesion weight by 78.89% (Pi0.001) and the para- 
site loads in infected footpads by 87.61% (PcO.001) versus 
the untreated mice. Effect of treatments with P. galioides 
petroleum ether extract or with the active compound isolat- 
ed by fractionation monitored by bioassays, grifolic acid, 
during the course of infection of BALBIc mice infected with 
L. amazonensis is presented in Fig. 2. No significant differ- 
ence was observed between the untreated BALBIc mice and 
treated mice with these compounds. In contrast, we have 
observed in grifolic acid treated mice a significant increas- 
ing of the weight lesions by 131.47% (subcutaneous via) 
and 182.51% (oral route) and the parasite loads by 
Fig. 1. The chemical structures of prenylated diphenols. 
183.41% (subcutaneous route) and 305.51% (oral route). 
The effects of P. galioides methylene chloride extract and 
the in vitro active compounds isolated from this extract by 
bioassay guided fractionation, grifolin and piperogalin are 
presented in Fig. 3. Also, none of these compounds could 
Table 2. Effect of treatments with N-methylglucamine antimonate by subcutaneous route, P. galioides extracts and prenylated phenols 
administered by oral or subcutaneous routes on Leishinania amazonensis infected BALB/c mice. 
Compounds (dose) Via adm.* (mean4D)2 of weight parasites load quantitation in 
Lesion wt (g) %Suppression YO Supression of Mean parasites 
lesion in the lesion the lesion 
None(control)6 
Meglumine antimonateC 
(28 mg Sb'/kg)xlS 
Petroleum ether extract 
(25 mg/kg)xlO 
Petroleum ether extract 
(25 mg/kg)xl5 
Methylene chloride 
extract - (25 mg/kg)xlO 
Methylene chloride 
extract - (25 mg/kg)xl5 
Piperogaline 
(25 mg/kg)xlO 
Piperogalin 
(25 mg/kg)xlS 
Grifolin 
(25 mg/kg)xlO 
Grifolin 
(25 mg/kg)xl5 
Grifolic acid 
(25 mg/kg)xlO 
Grifolic acid 
(25 mg/kg)xl5 
0.0660 f 0.0239 
0.0139 0.0106 
5.1 x lo6 
6.3 105 -78.89% 
(P<O.OOl)" 
+44.72% 
subcutaneous 
subcutaneous 
oral 
subcutaneous 
oral 
subcutaneous 
oral 
subcutaneous 
oral 
subcutaneous 
oral 
-87.61% 
(P<o.Ool);:. 
+40.5 8 % 0.0955 f 0.04477 7.14 x lo6 
5.9 x 106 
6.2 x lo6 
0.0849 2 0.0256 +28.53% +16.37% 
0.1016 2 0.0570 +53.63% +21.73 % 
1.0 107 
2.3 107 
0.0885 z 0.0142 +34.02% +99.96% 
0.2042 2 0.0312 
0.1818 2 0.0434 
0.1420 e 0.0370 
0.1617 z 0.0389 
(Pe0.003)" 
0.1529 0.0485 
0.1866 2 0.0651 
(Pe0.003)" 
(P<o.Ool):b 
(PeO.001)" 
(PeO.01)" 
(Pe0.02)'" 
+209.21 
+175.32% 
(PeO.05)" 
+114,99% 
(PeO.01)" 
+353.39% 
2.4 107 
9.9 x 106 
+362.59 
+94,55% 
1.4 107 
1.5 107 
+ 144.8 8 % 
(Pe0.02) 
+131.47% 
(Pe0.004)" 
+182.51% 
( P ~ 0 . 0 3 ) ' ~  
+169.67% 
+183.41% 
2.1 107 +305.51% 
Via administration 
Values represent the means 2 standard deviation, six mice per group were used. 
'' P values were also calculated by ANOVA. 
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reduce the progression of the L. amazonensis infection in 
the infected footpads. In contrast, it  seemed that they fa- 
voured a significant growth of parasites. 
The petroleum ether and methylene chloride extracts of 
P. galioides and the active prenylated-diphenols obviously 
exhibited an in vitro leishmanicidal properties. The confir- 
mation of the in vivo activity of these compounds on the 
course of infection BALBIc mice with L. amazonensis did 
not give the expected results. 
In conclusion, the data presented in this study indicate 
that a direct comparison between the efficacy of extracts or  
compounds against various strains of Leishmania is not al- 
ways evident (Croft, 1994; Hudson, 1994). It is not easy to 
specify wether the in vitro drug activity will correlate with 
its in vivo activity or not (Bell e t  all., 1990; Fournet et al., 
1993; Hocquemiller e t  al., 1991; Iwu e t  al., 1994). The in 
vitro activities of extracts and prenylated-diphenols on  ex- 
tracellular forms of Leishmania suggest that  its activity is 
coupled with cytotoxicity. 
Fig. 2. Effect of treatments with meglumine antimo- 
nate (Glucantime@) (100 mg per kg per days for 15 
days), petroleum ether extract of Peperomia gali- 
oides, grifolic acid administered orally at 25 mgkg 
once daily for 15 days or subcutaneously at  25 mg/kg 
for 1 0  days, during the course of infection of BALBk 
mice with L. amazonensis. Each point represents the 
mean difference in size t standard deviation of the 
mean between infected and uninfected footpads 
(n = 6). 
Fig. 3. Effect of treatments with meglumine antimo- 
nate (Glucantime@) (100 mg per kg per days for 15 
days), methylene chloride extract of P. galioides, grif- 
olin and piperogalin administered by subcutaneous 
route at 25 mg/kg for 10 days, during the course'of 
infection of BALBk mice with L. amazonensis. Each 
point represents the mean difference in size t stan- 
dard deviation of the mean between infected and un- 
infected footpads (n = 6). 
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